SCHEMBL7984382

SCHEMBL7984382

CCCC(=O)Nc1ncn(Cc2cccc(F)c2)c1C(N)=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 2/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ EGFR P00533 1/20 0.41
▸ FLT3 P36888 1/20 0.41
▸ HDAC1 Q13547 1/20 0.41
▸ CDK9 P50750 4/20 0.41
▸ TP53 P04637 1/20 0.40
▸ PKM P14618 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ GSK3A P49840 1/20 0.40
▸ GSK3B P49841 1/20 0.40
▸ FSCN1 Q16658 1/20 0.40
▸ AURKA O14965 2/20 0.39
▸ RPS6KB1 P23443 2/20 0.39
▸ AURKB Q96GD4 1/20 0.39
▸ NR3C2 P08235 1/20 0.39
▸ HSD17B13 Q7Z5P4 1/20 0.39
▸ F2R P25116 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7985670 0.92 CDK9 (0.42) ALDH1A1KDM4ECDK9FSCN1NR3C2
SCHEMBL7988379 0.88 KDM4E (0.50) KDM4EFLT3HDAC1TP53SMN1; SMN2
SCHEMBL7987680 0.87 HPGD (0.42) ALDH1A1KDM4EFLT3HDAC1TP53
SCHEMBL7987555 0.87 GAA (0.47) ALDH1A1KDM4EHDAC1CDK9PKM
SCHEMBL7988471 0.82 KDM4E (0.43) KDM4ESMN1; SMN2GSK3AGSK3BLMNA
SCHEMBL7988506 0.82 NTRK1 (0.48) NPC1ALDH1A1KDM4ECDK9RAB9A
SCHEMBL8061779 0.81 GSK3B (0.40) GSK3AGSK3B
SCHEMBL7991550 0.81 GAA (0.45) ALDH1A1HDAC1PKMGSK3A
SCHEMBL7987961 0.80 MAPT (0.47) ALDH1A1TP53PKMAURKARPS6KB1
SCHEMBL7987935 0.80 XDH (0.47) NPC1ALDH1A1HDAC1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 — — US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 — — EP disclosed
Send feedback